Phlorizin supplementation attenuates obesity, inflammation, and hyperglycemia in diet-induced obese mice fed a high-fat diet

Nutrients

Volumn 8, Issue 2, 2016, Pages

  Shin, Su Kyung ^a   Cho, Su Jung ^b   Jung, Un Ju ^c   Ryu, Ri ^b   Choi, Myung Sook ^b  

^a Keimyung University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c Pukyong National University   (South Korea)

Author keywords

High fat diet; Inflammation; Insulin resistance; Obesity; Phlorizin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; COMPLEMENT FACTOR D; FATTY ACID; GAMMA INTERFERON; GLUCAGON; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; PHLORIZIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CELL SIZE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET INDUCED OBESITY; ENZYME ACTIVITY; ESTERIFICATION; FATTY LIVER; FOOD INTAKE; HISTOPATHOLOGY; HOMEOSTASIS; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPOGENESIS; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; OBESITY; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; COMPLICATION; CYTOLOGY; DIETARY SUPPLEMENT; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; LIVER; MALUS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYTOTHERAPY;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; HYPERGLYCEMIA; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MALUS; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PHLORHIZIN; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84958523623     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8020092     Document Type: Article

References (35)

1. Petersen, C. Analyse des Phloridzins. Annal. Pharm. 1835, 15. [CrossRef].
2. Gosch, C.; Halbwirth, H.; Stich, K. Phloridzin: Biosynthesis, distribution and physiological relevance in plants. Phytochemistry 2010, 71, 838-843. [CrossRef] [PubMed].
3. Ehrenkranz, J.R.; Lewis, N.G.; Kahn, C.R.; Roth, J. Phlorizin: A review. Diabetes Metab. Res. Rev. 2005, 21, 31-38. [CrossRef] [PubMed].
4. Rossetti, L.; Smith, D.; Shulman, G.I.; Papachristou, D.; DeFronzo, R.A. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Investig. 1987, 79, 1510-1515. [CrossRef] [PubMed].
5. Rossetti, L.; Shulman, G.I.; Zawalich, W.; DeFronzo, R.A. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J. Clin. Investig. 1987, 80, 1037-1044. [CrossRef] [PubMed].
6. Takii, H.; Matsumoto, K.; Kometani, T.; Okada, S.; Fushiki, T. Lowering effect of phenolic glycosides on the rise in postprandial glucose in mice. Biosci. Biotechnol. Biochem. 1997, 61, 1531-1535. [CrossRef] [PubMed].
7. Prentice, A.M. The emerging epidemic of obesity in developing countries. Int. J. Epidemiol. 2006, 35, 93-99. [CrossRef] [PubMed].
8. Collins, S.; Martin, T.L.; Surwit, R.S.; Robidoux, J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: Physiological and molecular characteristics. Physiol. Behav. 2004, 81, 243-248. [CrossRef] [PubMed].
9. Buettner, R.; Schölmerich, J.; Bollheimer, L.C. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007, 15, 798-808. [CrossRef] [PubMed].
10. Prpic, V.;Watson, P.M.; Frampton, I.C.; Sabol, M.A.; Jezek, G.E.; Gettys, T.W. Differential mechanisms and development of leptin resistance in A/J vs. C57BL/6J mice during diet-induced obesity. Endocrinology 2003, 144, 1155-1163. [CrossRef] [PubMed].
11. Surwit, R.S.; Kuhn, C.M.; Cochrane, C.; McCubbin, J.A.; Feinglos, M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988, 37, 1163-1167. [CrossRef] [PubMed].
12. Tsunoda, N.; Ikemoto, S.; Takahashi, M.; Maruyama, K.; Watanabe, H.; Goto, N.; Ezaki, O. High-monounsaturated fat diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 1998, 47, 724-730. [CrossRef].
13. Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115, 911-919. [CrossRef] [PubMed].
14. Folch, J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509. [PubMed].
15. Hulcher, F.H.; Oleson,W.H. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J. Lipid Res. 1973, 14, 625-631. [PubMed].
16. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254. [CrossRef].
17. Nepokroeff, C.M.; Lakshmanan, M.R.; Porter, J.W. Fatty-acid synthase from rat liver. Methods Enzymol. 1975, 35, 37-44. [PubMed].
18. Walton, P.A.; Possmayer, F. Mg2-dependent phosphatidate phosphohydrolase of rat lung: Development of an assay employing a defined chemical substrate which reflects the phosphohydrolase activity measured using membrane-bound substrate. Anal. Biochem. 1985, 151, 479-486. [PubMed].
19. Markwell, M.A.; McGroarty, E.J.; Bieber, L.L.; Tolbert, N.E. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. J. Biol. Chem. 1973, 248, 3426-3432. [PubMed].
20. Lazarow, P.B. Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol. 1981, 72, 315-319. [PubMed].
21. Shapiro, D.J.; Nordstrom, J.L.; Mitschelen, J.J.; Rodwell, V.W.; Schimke, R.T. Micro assay for 3-hdyroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim. Biophys. Acta 1974, 370, 369-377. [CrossRef].
22. Gillies, P.J.; Rathgeb, K.A.; Perri, M.A.; Robinson, C.S. Regulation of acyl-CoA: Cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: Role of a cholesterol substrate pool. Exp. Mol. Pathol. 1986, 44, 329-339. [CrossRef].
23. Rebuffé-Scrive, M.; Surwit, R.; Feinglos, M.; Kuhn, C.; Rodin, J. Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism 1993, 42, 1405-1409. [CrossRef].
24. Surwit, R.S.; Feinglos, M.N.; Rodin, J.; Sutherland, A.; Petro, A.E.; Opara, E.C.; Kuhn, C.M.; Rebuffé-Scrive, M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995, 44, 645-651. [CrossRef].
25. Smith, S.R.; Lovejoy, J.C.; Greenway, F.; Ryan, D.; de Jonge, L.; de la Bretonne, J.; Volafova, J.; Bray, G.A. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001, 50, 425-435. [PubMed].
26. Assmann, G.; Gotto, A.M., Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 15, III8-III14.
27. Berg, A.H.; Scherer, P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 13, 939-949. [CrossRef] [PubMed].
28. Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L.; Ferrante, A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 2003, 112, 1796-1808. [CrossRef] [PubMed].
29. Fantuzzi, G.; Faggioni, R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 2000, 68, 437-446.
30. Fernández-Sánchez, A.; Madrigal-Santillán, E.; Bautista, M.; Esquivel-Soto, J.; Morales-González, A.; Esquivel-Chirino, C.; Durante-Montiel, I.; Sánchez-Rivera, G.; Valadez-Vega, C.; Morales-González, J.A. Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci. 2011, 12, 3117-3132. [CrossRef] [PubMed].
31. Baas, T. Adipsin meets β cells. SciBX 2014, 7. [CrossRef].
32. Bertolani, C.; Marra, F. The role of adipokines in liver fibrosis. Pathophysiology 2008, 15, 91-101. [CrossRef] [PubMed].
33. Friedman, S.L. Hepatic fibrosis-overview. Toxicology 2008, 254, 120-129. [CrossRef] [PubMed].
34. Das, S.; Santra, A.; Lahiri, S.; Guha Mazumder, D.N. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol. Appl. Pharmacol. 2005, 204, 18-26. [CrossRef] [PubMed].
35. Charlton, M.; Krishnan, A.; Viker, K.; Sanderson, S.; Cazanave, S.; McConico, A.; Masuoko, H.; Gores, G. Fast food diet mouse: Novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G825-G834. [CrossRef] [PubMed].